GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly emerging as a significant focus in therapeutic investigation, largely due to its notable impact on controlling diseases such as adult-onset diabetes and excess body fat. Recent trials have shown that beyond glucose regulation, GLP-1 drugs offer benefits for circulatory health an